Cytek Biosciences, Inc. (CTKB) News
Track canonical SquawkNews coverage tagged to CTKB, Cytek Biosciences, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 9 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
Industry’s First End-to-End Flow Cytometry Platform Covering Panel Design Through Data AnalysisCytek® Cloud digital ecosystemFREMONT, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosci
NEWS | Sep 23, 2026, 09:02 PM UTC
L
CTKB - Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
CTKB - Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
NEWS | Sep 23, 2026, 09:00 PM UTC
L
CTKB - Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
CTKB - Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
EQUITY | Sep 09, 2026, 12:31 PM UTC
L
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
FREMONT, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- As clinical laboratories seek deeper cellular insights, greater efficiency, and more streamlined approaches to cell analysis, spectral flow cytometry leader Cytek Biosc
EQUITY | Sep 03, 2026, 09:07 PM UTC
L
CTKB - Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS - Click For Releas
CTKB - Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
EQUITY | Sep 03, 2026, 09:00 PM UTC
L
Cytek Biosciences to participate in upcoming investor conferences
Cytek Biosciences (CTKB) announced it will participate in upcoming investor conferences, with a live and archived webcast available for an included event.
EQUITY | Sep 01, 2026, 08:07 PM UTC
L
CTKB - Cytek Biosciences to Participate in Upcoming Investor Conferences
CTKB - Cytek Biosciences to Participate in Upcoming Investor Conferences
EQUITY | Sep 01, 2026, 08:05 PM UTC
M
Cytek wins jury finding on three of four asserted claims
Cytek says a jury found in its favor on three of four asserted claims, and the company will challenge the remaining finding.
REGULATION | Aug 21, 2026, 08:35 PM UTC
L
Cytek Biosciences Raises FY2026 Sales Guidance from $205.000M-$212.000M to $207.000M-$212.000M vs $208.767M Est
Cytek Biosciences (NASDAQ: CTKB ) raises FY2026 sales outlook from $205.000 million-$212.000 million to $207.000 million-$212.000 million vs $208.767 million estimate.
EARNINGS | Aug 05, 2026, 08:06 PM UTC